gross profit bridgeinconsistent2021-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
Revenue
$875.26M
Fiscal year ended 2025-12-31Operating income
$275.62M
Fiscal year ended 2025-12-31Free cash flow
$245.60M
Fiscal year ended 2025-12-31Nutex Health Inc. (NUTX) reported revenue of $875.26M and net income of $70.79M for the fiscal year ended 2025-12-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Nutex Health Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Business Services, NEC.
Income
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $875.26M | $479.95M | $247.65M | $219.29M | $331.53M | $274.03M | $1.37M | $1.37M | $23.17K | $0 |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $830.44K | $507.64K | $30.48K | $0 |
| Gross profit | $444.28M | $196.26M | $34.77M | $15.42M | Unavailable | Unavailable | $535.98K | $859.36K | -$7.32K | $0 |
| Operating income | $275.62M | $130.70M | -$31.77M | -$406.60M | $170.26M | $153.17M | -$6.90M | -$840.40K | -$5.69M | -$448.60K |
| Net income | $70.79M | $52.10M | -$45.79M | -$424.78M | $132.59M | $105.97M | -$7.12M | -$950.13K | $582.06K | -$7.43M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | $285.88K | $557.26K | $768.10K | $545.22K | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 6.76M | shares 5.49M | shares 4.41M | shares 4.23M | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | shares 39.69M |
| Pretax income | $244.78M | $109.83M | -$48.49M | -$419.65M | $169.49M | $145.74M | -$7.12M | Unavailable | Unavailable | Unavailable |
| Income tax expense | $64.42M | $15.02M | -$5.07M | $13.09M | $965.73K | $181.34K | $0 | $0 | Unavailable | Unavailable |
| Diluted EPS | $10.48 | $9.69 | $-10.39 | $-100.36 | $0.22 | $0.18 | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling, general & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $4.24M | $1.15M | Unavailable | Unavailable |
| General & administrative | $51.65M | $41.92M | $33.23M | $19.81M | $5.46M | $4.43M | $3.67M | $945.61K | $1.81M | $448.60K |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $166.76K | $577.74K | $208.92K | Unavailable | Unavailable |
Balance
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $185.57M | $40.64M | $22.00M | $34.26M | $36.12M | $26.93K | $1.07M | $119.27K | $9.45K | $10.52K |
| Total assets | $918.52M | $655.32M | $398.25M | $431.75M | $394.65M | $169.86K | $6.69M | $449.43K | $3.33M | $510.84K |
| Current assets | $538.81M | $292.48M | $90.85M | $97.97M | $154.02M | $157.06K | $1.24M | $305.42K | $55.08K | $507.93K |
| Total liabilities | $495.09M | $466.79M | $319.14M | $311.42M | $203.07M | $1.30M | $4.83M | $1.95M | $959.78K | $6.38M |
| Current liabilities | $157.91M | $154.22M | $58.31M | $54.86M | $37.69M | $1.15M | $4.61M | $1.04M | $959.78K | $6.38M |
| Total equity incl. NCI | $423.44M | $188.53M | $79.11M | $120.33M | $191.58M | $147.37M | $50.84M | -$1.50M | -$997.22K | -$5.87M |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $2.87M | $2.85M | $3.39M | $3.53M | $2.81M | $0 | $26.99K | $0 | $0 | Unavailable |
| Accounts receivable | Unavailable | $232.45M | $58.60M | $57.80M | $112.77M | $18.28K | $100.18K | $186.15K | $6.25K | $0 |
| Goodwill | $13.92M | $13.92M | $17.07M | $17.01M | $1.14M | $0 | $3.47M | $0 | Unavailable | $0 |
| Long-term debt | $29.17M | $22.47M | $26.31M | $23.05M | $78.82M | $0 | $0 | $300.00K | Unavailable | Unavailable |
| Accounts payable | Unavailable | $9.61M | $18.90M | $23.61M | $13.58M | Unavailable | Unavailable | Unavailable | Unavailable | $356.00K |
Cash flow
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $248.12M | $23.15M | $1.26M | $50.61M | $173.43M | $86.67M | -$4.04M | -$480.05K | -$714.62K | -$274.22K |
| Capital expenditures | $2.53M | $2.30M | $9.50M | $14.63M | $36.93M | $61.19M | $84.00K | $0 | Unavailable | Unavailable |
| Investing cash flow | -$5.24M | -$5.61M | -$11.24M | -$4.34M | -$36.98M | -$61.19M | -$748.20K | -$116.96K | $2.05K | -$9.99K |
| Financing cash flow | -$97.95M | $1.09M | -$2.27M | -$48.13M | -$125.85M | -$7.97M | $5.73M | $704.57K | $711.50K | $172.44K |
| Net change in cash | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | -$1.04M | $946.17K | $107.56K | -$1.07K | -$111.77K |
| Stock-based compensation | Unavailable | Unavailable | Unavailable | $189.58K | $4.03M | $2.57M | $450.05K | $155.89K | $924.33K | $1.50K |
| Common dividends paid | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Common share repurchases | $5.00M | $0 | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | $20.53M | $18.97M | $17.59M | $13.13M | $7.66M | $5.90M | $156.09K | $2.68K | Unavailable | Unavailable |
Derived
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $245.60M | $20.85M | -$8.24M | $35.97M | Unavailable | $25.48M | -$4.12M | -$480.05K | Unavailable | Unavailable |
| Gross margin | 50.8% | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% | 39.2% | 62.9% | -31.6% | Unavailable |
| Operating margin | 31.5% | 27.2% | -12.8% | -185.4% | 51.4% | 55.9% | -504.8% | -61.5% | -24574.5% | Unavailable |
| FCF margin | 28.1% | 4.3% | -3.3% | 16.4% | Unavailable | 9.3% | -301.9% | -35.1% | Unavailable | Unavailable |
| SBC / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 32.9% | 11.4% | 3990.0% | Unavailable |
| Current ratio | 3.41x | 1.90x | 1.56x | 1.79x | 4.09x | 0.14x | 0.27x | 0.29x | 0.06x | 0.08x |
| Revenue YoY growth | 82.4% | 93.8% | 12.9% | -33.9% | 21.0% | 19954.5% | -0.0% | 5800.9% | Unavailable | Unavailable |
| Net margin | 8.1% | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% | -520.8% | -69.5% | 2512.6% | Unavailable |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | 56.2% | 39.9% | Unavailable | Unavailable |
| CapEx / revenue | 0.3% | 0.5% | 3.8% | 6.7% | Unavailable | 22.3% | 6.1% | 0.0% | Unavailable | Unavailable |
| Long-term debt / equity | 0.07x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 26.3% | 13.7% | Unavailable | Unavailable | 0.6% | 0.1% | Unavailable | Unavailable | Unavailable | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open NUTX in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-04-30View SEC filing
10-K · Filed 2026-03-05View SEC filing
10-Q · Filed 2025-11-19View SEC filing
10-K/A · Filed 2025-11-18View SEC filing
10-Q/A · Filed 2025-11-18View SEC filing
Reconciliation checks needing review
6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2020-12-31
Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.
balance equationreview2020-12-31
Difference 148502620 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
cash flow reconciliationreview2020-12-31
Operating, investing and financing flows differ from the reported change in cash by 18548528, beyond tolerance 1000000.
balance equationreview2019-12-31
Difference 48977142 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.
balance equationreview2017-12-31
Difference 3366199 exceeds tolerance 1000000. Presentation or filing-vintage differences need review.